(Q36973276)

17 August 2017

1 reference

title

Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia (English)

1 reference

therapy-related acute myeloid leukemia

17 August 2017

0 references

1 reference

J Yang

1

1 reference

17 August 2017

A Bogni

2

1 reference

17 August 2017

C Cheng

3

1 reference

17 August 2017

W K Bleibel

4

1 reference

17 August 2017

X Cai

5

1 reference

17 August 2017

Y Fan

6

1 reference

17 August 2017

W Yang

7

1 reference

17 August 2017

J C C Rocha

8

1 reference

17 August 2017

D Pei

9

1 reference

17 August 2017

W Liu

10

1 reference

17 August 2017

M E Dolan

11

1 reference

17 August 2017

C-H Pui

12

1 reference

17 August 2017

M V Relling

13

1 reference

17 August 2017

language of work or name

English

0 references

publication date

28 May 2008

1 reference

Clinical Pharmacology & Therapeutics

17 August 2017

1 reference

17 August 2017

84

1 reference

17 August 2017

691-697

1 reference

17 August 2017

6

1 reference

Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Effect of population and gender on chemotherapeutic agent-induced cytotoxicity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Modeling oncogenic translocations: distinct roles for double-strand break repair pathways in translocation formation in mammalian cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Radiation and the microenvironment - tumorigenesis and therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

CEPH individuals are representative of the European American population: implications for pharmacogenetics.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

New insight into the molecular mechanisms of MLL-associated leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Genome-wide discovery of loci influencing chemotherapy cytotoxicity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

MLL-rearranged leukemias: insights from gene expression profiling

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Topoisomerase II inhibitor-related acute myeloid leukaemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

The secondary leukemias: challenges and research directions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

In vivostability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.

27 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.86

Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.86

Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.86

Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.86

Etoposide induces chimeric Mll gene fusions

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583166

Acute nonlymphoblastic leukemia in children treated for acute lymphoblastic leukemia with an intensive regimen including teniposide

4 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.86

Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung

21 January 2018

1 reference

12 December 2020

Current approaches to therapy for childhood lymphoblastic leukemia: St. Jude studies XI (1984-1988) and XII (1988)

1 reference

12 December 2020

Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II

1 reference

12 December 2020

Epipodophyllotoxin-related acute myeloid leukaemia

1 reference

12 December 2020

High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma

1 reference

12 December 2020

Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II

1 reference

12 December 2020

L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins

1 reference

12 December 2020

Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases

1 reference

12 December 2020

Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells

1 reference

12 December 2020

Modifying risks of secondary leukemias: is drug scheduling important?

1 reference

12 December 2020

Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide

1 reference

12 December 2020

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia

1 reference

12 December 2020

Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors

1 reference

12 December 2020

Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme

1 reference

12 December 2020

Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors

1 reference

12 December 2020

Genome scan implicates adhesion biological pathways in secondary leukemia

1 reference

12 December 2020

Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25

1 reference

12 December 2020

Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia

1 reference

12 December 2020

Acute myelogenous leukemia after treatment for malignant germ cell tumors in children

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.86

7 January 2021

inferred from DOI database lookup

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.86

7 January 2021

inferred from DOI database lookup

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.86

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/CLPT.2008.86

1 reference

17 August 2017

1 reference

17 August 2017

1 reference